CS logo
small CS logo
Medplus Nordrhein

Krefeld, Nordrhein-Westfalen, Germany
Obstetrician-gynecologist in Krefeld, North Rhine-Westphalia
Neue Linner Str. 86, 47799 Krefeld

About Medplus Nordrhein


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Total Rows: 1

Clinical Trials at Medplus Nordrhein


During the past decade, Medplus Nordrhein conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110000Started TrialsCompleted Trails2021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)
2021-10-29
2023-10-05
Active, not recruiting
400
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
2022-10-14
2024-12-07
Recruiting
405

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Medplus Nordrhein


According to Clinical.Site data, the most researched conditions in "Medplus Nordrhein" are "Hot Flashes" (2 trials), "Vasomotor Symptoms Associated With Menopause" (1 trials) and "Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Medplus Nordrhein" in a lesser frequency.

Clinical Trials Intervention Types at Medplus Nordrhein


Most popular intervention types in "Medplus Nordrhein" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Elinzanetant (BAY3427080)" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Medplus Nordrhein


The vast majority of trials in "Medplus Nordrhein" are 2 trials for "Female" genders.

Clinical Trials Status at Medplus Nordrhein


Currently, there are NaN active trials in "Medplus Nordrhein". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medplus Nordrhein, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medplus Nordrhein, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status